Glaucoma research grants awarded

Article

The International Glaucoma Association (IGA) will be awarding five grants totaling ?255 000 for critical glaucoma research.

The International Glaucoma Association (IGA) will be awarding five grants totaling £255 000 for critical glaucoma research.

Increased by 60% since last year, the grants will be awarded to professionals specializing in glaucoma research and patient care. This will include a grant of £90 000 for the Royal College of Ophthalmology joint award, £90 000 for the UK and Eire Glaucoma Society joint award, £30 000 for the IGA and College of Optometrists award, £30 000 for the Royal College of Nursing award and £15 000 for the Fight for Sight glaucoma research award.

Russell Young, CEO of the IGA, commented, “Since IGA was first formed in 1974, research has been central to our work. We are committed to supporting the many professionals who work tirelessly to investigate, manage and care for people with glaucoma."

"It is this work that enables us to provide accurate, evidence-based support and information to people living with glaucoma and to realise that much more needs to be done to reach the 300 000 people who have yet to be diagnosed, and are at serious risk of vision loss."

For further details about the awards and a list of deadlines please click here.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.